View More View Less
  • 1 Isotope Production Division, Pakistan Institute of Nuclear Science and Technology, P. O. Nilore, Islamabad, Pakistan
Restricted access

Abstract  

Radiolabeled somatostatin analogues, including octreotate have been used for targeted radiotherapy of neuroendocrine tumors such as lymphoma, breast cancer, small-cell lung cancer and melanoma. In this paper, studies on the optimization of the production of 177Lu, 166Ho and 153Sm radionuclides in Pakistan Atomic Research Reactor (PARR-I) and the investigations on the labeling of DOTA-Tyr-3 Octreotate with 131I, 177Lu, 166Ho and 153Sm have been reported. The labeled DOTA-Tyr3-Octreotate complexes were found to be stable in acetate/ascorbate buffer and saline at room temperature (18–22°C). The biodistribution studies of 177Lu-DOTA-Tyr-3 Octreotate in rat model indicated that the critical organ for this complex was the pancreas and the excretion route was through kidney.